Strategic Collaboration in Transplantation
Interested in participating in a clinical trial? Looking to collaborate with VPS? Want to showcase organ preservation innovations in the media?
We’d love to hear from you!
Key Collaborations
Duke University
Collaborating with Duke University to explore the use of the VP.S ENCORE® platform for targeted delivery of viral vectors to donor organs, enabling genetic modification for therapeutic and immunologic optimization.
This work also includes pediatric models, from neonates to infants, with the goal of expanding the donor pool and improving transplant access across all age groups.
The Texas Heart Institute
Working with the Texas Heart Institute to conduct orthotopic preclinical heart transplant studies using the VP.S ENCORE® platform, generating critical data to support regulatory submissions and demonstrate performance in clinically relevant models.
University of Texas at San Antonio
Partnering with UT Health San Antonio to drive translational science, clinical strategy, and early-stage validation of organ preservation approaches.
Wyss Institute
Collaborating with the Wyss Institute on breakthrough perfusate technologies designed for use with the VP.S ENCORE® platform, supported by funding from Advanced Research Projects Agency for Health (ARPA-H). This work is focused on enabling prolonged organ preservation and advancing toward the future of organ banking.
San Antonio Medical Foundation
Supported by the San Antonio Medical Foundation to advance kidney preservation using the VP.S ENCORE® platform, including research focused on optimizing perfusion strategies to improve transplant outcomes.
Unravel Biosciences
Partnering with Unravel Biosciences to explore the use of their AI-driven BioNAV™ platform in identifying and evaluating perfusate additives with the potential to reduce primary graft dysfunction and improve post-transplant outcomes as part of a broader effort to develop a next-generation cardiac perfusion solution.